Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,545
Closed -$342K 1834
2026
Q1
$342K Buy
1,545
+685
+80% +$168K 0.01% 1015
2025
Q4
$218K Sell
860
-303
-26% -$76.1K 0.01% 1240
2025
Q3
$288K Buy
+1,163
New +$278K 0.01% 1064
2025
Q1
Sell
-1,585
Closed -$326K 1555
2024
Q4
$326K Sell
1,585
-256
-14% -$56.2K 0.02% 832
2024
Q3
$447K Buy
+1,841
New +$431K ﹤0.01% 2926
2024
Q1
Sell
-1,587
Closed -$349K 4393
2023
Q4
$349K Buy
+1,587
New +$336K ﹤0.01% 3084

Other funds holding STE

GTS Securities's STE Position: Q2 2026 in Review

GTS Securities sold out of Steris (STE) in Q2 2026, closing a stake of 1,545 shares — an estimated $342K sold.

GTS Securities first reported a position in STE in Q4 2023 and held it in 6 quarters. The position peaked at $447K in Q3 2024. 837 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • GTS Securities reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,545 Steris shares in Q2 2026, an estimated $342K.
  • GTS Securities first reported a position in Steris in Q4 2023 and held it in 6 quarters.
  • GTS Securities's Steris position peaked at $447K in Q3 2024.
  • 837 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.